Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Isetta

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Reumatologia|February 7, 2024
Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumaticaCiro Manzo, Alberto Castagna, Nicola Veronese, et al.
Journal of Personalized Medicine|March 25, 2022
The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future ScenariosCiro Manzo, Elvis Hysa, Alberto Castagna, et al.
Rheumatology (Oxford, England)|May 8, 2024
Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirementCiro Manzo, Maria Natale, Marco Isetta, et al.
Medical Hypotheses|January 10, 2021
Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?Ciro Manzo, Jordi Serra-Mestres, Marco Isetta, et al.
Medicines (Basel, Switzerland)|August 4, 2018
Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with GlucocorticoidsCiro Manzo, Jordi Serra-Mestres, Alberto Castagna, et al.
Reumatologia|July 18, 2025
When can calcium pyrophosphate deposition disease be considered a polymyalgia rheumatica mimicking disease?Ciro Manzo, Paolo Falsetti, Alberto Castagna, et al.
Joint Bone Spine|September 10, 2021
Early diagnosis in patients with polymyalgia rheumatica: is a fast track clinic a viable solution? Comment on: "Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation" by Frølund et al. Joint Bone Spine 2021;88:105185Ciro Manzo, Marcin Milchert, Marco Isetta, et al.
Medicines (Basel, Switzerland)|June 2, 2021
Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative ReviewSharadha Wisidagama, Abiram Selladurai, Peter Wu, et al.
Brain Sciences|April 18, 2019
Cognitive Function in Primary Sjögren's Syndrome: A Systematic ReviewCiro Manzo, Eva Martinez-Suarez, Melek Kechida, et al.
European Child & Adolescent Psychiatry|June 6, 2021
Catatonia in pediatric obsessive-compulsive disorder: report of two casesWalter Jaimes-Albornoz, EunJoo Lee, Jordi Serra-Mestres, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Reumatologia|February 7, 2024
Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumaticaCiro Manzo, Alberto Castagna, Nicola Veronese, et al.
Journal of Personalized Medicine|March 25, 2022
The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future ScenariosCiro Manzo, Elvis Hysa, Alberto Castagna, et al.
Rheumatology (Oxford, England)|May 8, 2024
Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirementCiro Manzo, Maria Natale, Marco Isetta, et al.
Medical Hypotheses|January 10, 2021
Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?Ciro Manzo, Jordi Serra-Mestres, Marco Isetta, et al.
Medicines (Basel, Switzerland)|August 4, 2018
Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with GlucocorticoidsCiro Manzo, Jordi Serra-Mestres, Alberto Castagna, et al.
Reumatologia|July 18, 2025
When can calcium pyrophosphate deposition disease be considered a polymyalgia rheumatica mimicking disease?Ciro Manzo, Paolo Falsetti, Alberto Castagna, et al.
Joint Bone Spine|September 10, 2021
Early diagnosis in patients with polymyalgia rheumatica: is a fast track clinic a viable solution? Comment on: "Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiation" by Frølund et al. Joint Bone Spine 2021;88:105185Ciro Manzo, Marcin Milchert, Marco Isetta, et al.
Medicines (Basel, Switzerland)|June 2, 2021
Recognition and Management of Antipsychotic-Induced Parkinsonism in Older Adults: A Narrative ReviewSharadha Wisidagama, Abiram Selladurai, Peter Wu, et al.
Brain Sciences|April 18, 2019
Cognitive Function in Primary Sjögren's Syndrome: A Systematic ReviewCiro Manzo, Eva Martinez-Suarez, Melek Kechida, et al.
European Child & Adolescent Psychiatry|June 6, 2021
Catatonia in pediatric obsessive-compulsive disorder: report of two casesWalter Jaimes-Albornoz, EunJoo Lee, Jordi Serra-Mestres, et al.
Pageof 3